Navigation Links
Researchers unveil strategy for creating actively-programmed anti-cancer molecules

The new study, which was published July 5 in an advanced, online edition of the Proceedings of the National Academy of Sciences, achieved a significant enhancement of the treatment of metastatic breast cancer in animal models. The study showed the new hybrid compound remained in circulation for a week. In comparison, the small molecule drug was cleared in a matter of minutes.

"Although the study focused specifically on breast cancer, these new findings could have broad application in the treatment of a number of other cancers, potentially increasing the efficacy of a number of existing or undeveloped small molecule therapies," said Subhash C. Sinha, Ph.D., associate professor in the Scripps Research Department of Molecular Biology and the Skaggs Institute for Chemical Biology, who led the research with Scripps Research President Richard A. Lerner, M.D., Lita Annenberg Hazen Professor of Immunochemistry, Cecil H. and Ida M. Green Chair in Chemistry, and a member of the Skaggs Institute for Chemical Biology.

In the study, the scientists created what is known as a "chemically programmed antibody" by using small cell-targeting molecules and a non-targeting catalytic monoclonal aldolase antibody in a novel self-assembly strategy. Antibodies are proteins produced by immune cells that are designed to recognize foreign pathogens harmful to the body; monoclonal antibodies are produced in the laboratory from a single cloned B-cell, the immune system cell that makes antibodies.

"By bringing together chemistry and biology, our approach provides a way to break the traditional one antibody-one target axiom of immunochemistry," said Lerner. "This new hybrid technology offers great possibilities for the enhanced treatment and diagnosis of a variety of diseases, including cancer."

Preventing Breast Cancer Metastasis

In the study, the researchers used the unique assembly strategy to create a novel compound to combat metastatic brea
'"/>

Source:Scripps Research Institute


Page: 1 2 3

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain

Post Your Comments:
(Date:11/30/2009)... advantage of lower early bird registration rates ...sis congress of 2010 at http://www.iofwco-ecceo10...ess of the International Osteoporosis Foundation (...nomic Aspects of Osteoporosis and Osteoarthritis (...he world are expected to attend. The exciting scie...
(Date:11/30/2009)...ou ever thought the stress of seeing your extended...d news: a new research report in the December 2009... ( http://www.jleukbio.org ) shows that you might ...ame study might lead to entirely new treatments th...itis, and eczema under control. That,s because res...
(Date:11/30/2009)... , VILNIUS, Lithuania, Nov. 30 /PRNewswi...y.com ), a provider of high-precision biometric id...grades in the company,s core product line: VeriLo...recognition and MegaMatcher 3.1 SDK for large-sc...tification systems (AFIS). Expanded capabilities i...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Dendreon Reports Second Quarter 2009 Financial Results 13487 1Dendreon Reports Second Quarter 2009 Financial Results 13487 2Dendreon Reports Second Quarter 2009 Financial Results 13487 3Dendreon Reports Second Quarter 2009 Financial Results 13487 4Dendreon Reports Second Quarter 2009 Financial Results 13487 5Dendreon Reports Second Quarter 2009 Financial Results 13487 6Ingenuitys Technology Powers BD Cell Pathways Tool on New BD Biosciences Website 13485 1Ingenuitys Technology Powers BD Cell Pathways Tool on New BD Biosciences Website 13485 2Integrated Medical Systems Receives 243 25 Million from the U S Army for Worlds First Suitcase Intensive Care Unit 54144 1Integrated Medical Systems Receives 243 25 Million from the U S Army for Worlds First Suitcase Intensive Care Unit 54144 2Integrated Medical Systems Receives 243 25 Million from the U S Army for Worlds First Suitcase Intensive Care Unit 54144 3
...he journal Cancer Cell describes a small molecule ...ead to a new avenue for targeted cancer therapy. T...an tumors in a mouse model system and has low toxi...al evaluation of this compound in phase I clinical...e in driving cell division. High levels of Plk1 ha...
...Angola has reported 266 cases of Marburg haemorrha... Province, which remains the epicentre of the outb...e reported as of 21 April. , Assessment of the out...k in Angola began one month ago, on 22 March. The ...nditions in Angola, have been an extreme test of i...
... how external information gets transmitted from ou...that trigger particular responses. But cell signal...been a slow, arduous process. , Now, a research te...new method for charting cellular signaling network... the April 22 issue of Science. , To function pro...
Other Biology News:New drug shows promise as powerful anticancer agent 2Marburg haemorrhagic fever in Angola update 2Marburg haemorrhagic fever in Angola update 3Computational Method Speeds Mapping of Cell Signaling Networks 2Computational Method Speeds Mapping of Cell Signaling Networks 3
(Date:12/1/2009)..., HARBIN, China, Dec. 1 /PRNewswire-Asia-Fir... One Medical" or "the Company") (Nasdaq: CSKI ), ...developing and producing,over-the-counter drugs in...ounced that the Company has engaged Guangdong Medi...("MDK") to serve as its exclusive sales agent for ...
(Date:12/1/2009)...LANTA, Dec. 1 GeoVax La..."), an Atlanta-based, biopharmaceutical company de...-1 (Human Immunodeficiency Virus) and other infect... AIDS Day. ,, "Today is the 21st World AIDS Day...eir fight with the HIV/AIDS pandemic, we remain fo...
(Date:12/1/2009)... The two humanitarian organizations will ...cluding biomedical repair technologies. Their shar...African country of Togo. , ...recent signing of a Memorandum of Understanding, M...zed a partnership to help develop sustainable infr...
(Date:12/1/2009)... Michael R. Drapp, a 34-year veteran of t...rade; Technologies, a business development and int...he emerging nanotechnology space. The company als...t as a nanotechnology incubator. , ... Michael R. Drapp , a 34-year veteran of the high...
Breaking Biology Technology:China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6Mercy Ships and MediSend International Partner to Deliver Hope and Healing 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4
...e Centers for Medicare and Medicaid Services (CMS)...West temporary Total Artificial Heart (TAH-t) thro...des, MS-DRG 001 and 002. In addition, CMS also app...nology add-on payments for FY 2009, which starts O...riz. (Business Wire EON) August 7, 2008 -- On May...
...,Biotechnology Inc., (TSX: IXS.V; OTC Bulletin Boa...opment company commercializing the,next generation...ss Linking,(DXL(TM)) technology, announced today t... DXL625 (CD20), the company,s lead program., "We ...625, an antibody,directed against the B-cell marke...
...r Research in,Music Medicine, Inc. (ARIMM) announc...ill be held September 12-13, 2008, at the Indiana,...pus., For online registration and more informatio...This year,s conference theme is ,Music and Medicin...ela LaSalle, the co-founder and Chairman,of the Bo...
Other Biology Technology: CardioWest™ Artificial Heart Approved For Highest Reimbursement in CMS History : Plus Up To $53,000 New Technology Add-on Payments 2InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625 2The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008 2
Rat Anti-Human CBFA1 / RUNX2 Monoclonal Antibody, Unconjugated, Clone 232902 from R&D Systems
Rabbit Complement from Pel-Freez Biologicals
TrypLE Select 10X from Invitrogen
Goat Anti-PINX1 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: